By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Fidia Farmaceutici, S.p.A. 

Via Ponte della Fabbrica 3/A

Abano Terme  Padova  35031  Italy
Phone: 39-049-8232111 Fax: 39-049-810653



Company News
Fidia Farmaceutici, S.p.A. Introduces Hymovis, A Next-Generation Hyaluronan, At The AAOS Annual Meeting In Orlando 2/25/2016 12:11:49 PM
Fidia Farmaceutici, S.p.A. Presents Hymovis, A New Generation Hyaluronan, At The American College of Rheumatology Annual Meeting In San Francisco 11/2/2015 9:01:41 AM
Fidia Farmaceutici, S.p.A. Enters The Italian Pediatric Market Segment 7/2/2015 9:36:21 AM
Fidia Farmaceutici, S.p.A. To Attend The 32nd Annual J.P. Morgan Investors Healthcare Conference 1/6/2014 6:18:15 AM
Fidia Farmaceutici, S.p.A. to Distribute and Promote HYALGAN(R) (sodium hyaluronate) for Treatment of Osteoarthritis 9/26/2011 12:13:36 PM
Sanofi Release: HYALGAN(R) (sodium hyaluronate) Commercial Rights Transfer Back to Fidia Farmaceutici, S.p.A. 9/15/2011 10:59:53 AM
Anika Therapeutics (ANIK) Buys Italian Firm, Fidia Farmaceutici, S.p.A. for $34 Million 1/4/2010 6:55:40 AM
Fidia Farmaceutici, S.p.A. Release: Fidia Farmaceutici, S.p.A.'s European Patent on Cross-Linked Gel Slurries Has Been Entirely Revoked by the EPO Board of Appeal 12/2/2008 9:13:14 AM
APR Applied Pharma Research S.A. Receive IND Approval From FDA for a New NSAID Matrix Patch Product 11/17/2008 8:43:10 AM
Akorn, Inc. (AKRN) Signs A Definitive Agreement With Fidia Farmaceutici, S.p.A. To Develop Four ANDA Drug Products For Commercialization 5/2/2006 11:45:57 AM